“…Diazoxide stimulates the sulfonylurea receptor 1 subunit of adenosine triphosphate-sensitive potassium (K-ATP) channels on pancreatic beta cells, resulting in increased potassium efflux, cell hyperpolarization, reduced calcium influx, and thus suppression of calcium-mediated insulin secretion [5,7,8]. Potential adverse effects include edema, heart failure, pulmonary hypertension, ileus, necrotizing enterocolitis, vomiting, diabetic ketoacidosis, hyperuricemia, thrombocytopenia, and neutropenia [3,7,[9][10][11][12]. Overdose is infrequently reported [13].…”